Chuyu Yun
Overview
Explore the profile of Chuyu Yun including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
1089
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Qu Q, Chen Y, Wang Y, Long S, Wang W, Yang H, et al.
Nature
. 2025 Jan;
638(8050):E6.
PMID: 39875609
No abstract available.
2.
Wu J, Wang K, Qi X, Zhou S, Zhao S, Lu M, et al.
Cell Host Microbe
. 2025 Jan;
33(1):119-136.e11.
PMID: 39788092
Polycystic ovary syndrome (PCOS) affects 6%-10% of women of reproductive age and is known to be associated with disruptions in the gut bacteria. However, the role of the gut mycobiota...
3.
Ding S, Li W, Xiong X, Si M, Yun C, Wang Y, et al.
J Ovarian Res
. 2024 Dec;
17(1):250.
PMID: 39702491
Objective: To investigate the changes in bile acid (BA) metabolites within the follicular fluid (FF) of patients with diminished ovarian reserve (DOR) and to identify novel diagnostic markers that could...
4.
Qu Q, Chen Y, Wang Y, Long S, Wang W, Yang H, et al.
Nature
. 2024 Dec;
PMID: 39695227
Calorie restriction (CR) is a dietary intervention used to promote health and longevity. CR causes various metabolic changes in both the production and the circulation of metabolites; however, it remains...
5.
Liao B, Chen W, Qi X, Yun C, Pang Y
Mol Hum Reprod
. 2024 Oct;
30(10).
PMID: 39423135
Polycystic ovary syndrome (PCOS) is a common reproductive endocrine disease, which leads to serious impairment of reproductive health in women of child-bearing age. Anovulation or oligo-ovulation is a common clinical...
6.
Zhao M, Liao B, Yun C, Qi X, Pang Y
Reprod Biol Endocrinol
. 2024 Aug;
22(1):98.
PMID: 39107809
Background: At present, a number of clinical trials have been carried out on GLP-1 receptor agonist liraglutide in the treatment of polycystic ovary syndrome (PCOS). However, the effect of liraglutide...
7.
Xia J, Chen H, Wang X, Chen W, Lin J, Xu F, et al.
Nat Commun
. 2024 Jun;
15(1):4755.
PMID: 38834568
Non-alcoholic steatohepatitis (NASH) is a severe type of the non-alcoholic fatty liver disease (NAFLD). NASH is a growing global health concern due to its increasing morbidity, lack of well-defined biomarkers...
8.
Yun C, Yan S, Liao B, Ding Y, Qi X, Zhao M, et al.
Nat Metab
. 2024 May;
6(5):947-962.
PMID: 38769396
Polycystic ovary syndrome (PCOS), an endocrine disorder afflicting 6-20% of women of reproductive age globally, has been linked to alterations in the gut microbiome. We previously showed that in PCOS,...
9.
Wang X, Zhou S, Hu X, Ye C, Nie Q, Wang K, et al.
Cell Host Microbe
. 2024 May;
32(6):964-979.e7.
PMID: 38754418
The gut microbiota is closely linked to atherosclerosis. However, the role of intestinal fungi, essential members of the complex microbial community, in atherosclerosis is poorly understood. Herein, we show that...
10.
Chen W, Liao B, Yun C, Zhao M, Pang Y
J Ovarian Res
. 2024 May;
17(1):100.
PMID: 38734641
Background: Polycystic ovary syndrome (PCOS) is a reproductive endocrine disorder with multiple metabolic abnormalities. Most PCOS patients have concomitant metabolic syndromes such as insulin resistance and obesity, which often lead...